Citi Research forecasts Square can grow its sales by 29 percent annually through 2019. » Read More
By: Dan Mangan
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars. » Read More
By: John Melloy
Fundstrat says the Facebook, Amazon, Netflix and Google-parent Alphabet stocks basket now has a value of $1.3 trillion. » Read More
By: Evelyn Cheng
Kraft Heinz's proposed Unilever merger marks another consolidation effort in the food industry by 3G Capital and Warren Buffett's Berkshire Hathaway. » Read More
CEO Mark Dunkerley said lower fuel costs and strong demand propelled the strong quarterly results.
In a world of disappearing market returns and negative interest rates, the search for growth has become increasingly difficult, Goldman Sachs says.
Sell Pandora shares on weak profit potential, Pacific Crest said.
Despite Chipotle stock's 5 percent jump on Friday, some analysts are telling investors not to buy.
A wave of profit-taking would be no surprise following a nine-day win streak for the Dow, Needham's Chris Retzler says.
The Republicans' pledge to support the U.S. shale oil and gas industry would likely bolster U.S. drillers, Daniel Yergin said.
BTIG just downgraded Facebook to neutral from buy, saying "shortfalls vs. expectations could be painful."
With the S&P 500 surging to records, Oppenheimer's Ari Wald says recent history suggests more gains are likely soon.
Raymond James just downgraded Twitter to market perform from outperform.
The "Fast Money" traders share their first moves for the market open.
Some of the names on the move ahead of the open.
Dunkin' Brands CEO Nigel Travis talks about the company's future.
Jim Cramer issued a warning to those wary of the stock market – listen up!
Jim Cramer spoke with the CEO of Campbell Soup, who said they are leading the charge for a major change in the food industry.
GM's blowout report today just gave a big boost to quarterly estimates.
Rather than the major disruptive factor to the global economy and financial markets, the decision has had a decidedly muted effect.
Elon Musk’s new master plan will test shareholders' faith, according to Breakingviews.
News that the company has agreed to a deal with activist Elliott Management sent stock higher Thursday.
Big drug discoveries have been scant, but investors can find long-term value in some biotech names, said Mark Schoenebaum of Evercore ISI.
CEO Steve Mollenkopf attributed the strong results to the company's execution of a strategy it laid out in 2015.
Get the best of CNBC in your inbox